INR 316.35
(2.03%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.18 Billion INR | -34.56% |
2022 | 2.46 Billion INR | 11.57% |
2021 | 2.2 Billion INR | 36.53% |
2020 | 1.61 Billion INR | 15.86% |
2019 | 1.39 Billion INR | 10.03% |
2018 | 1.26 Billion INR | 2.46% |
2017 | 1.23 Billion INR | 20.68% |
2016 | 1.02 Billion INR | 26.39% |
2015 | 812.06 Million INR | 40.49% |
2014 | 578.03 Million INR | 26.09% |
2013 | 458.41 Million INR | 18.46% |
2012 | 386.97 Million INR | 15.96% |
2011 | 333.71 Million INR | 10.66% |
2010 | 301.58 Million INR | 20.98% |
2009 | 249.28 Million INR | 24.1% |
2008 | 200.87 Million INR | 16.85% |
2007 | 171.91 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 432.47 Million INR | 9.81% |
2023 Q1 | 669.39 Million INR | 5.23% |
2023 Q4 | 393.84 Million INR | 0.0% |
2023 FY | 1.61 Billion INR | -34.56% |
2023 Q2 | 706.97 Million INR | 5.61% |
2023 Q3 | 393.84 Million INR | -44.29% |
2022 FY | 2.46 Billion INR | 11.57% |
2022 Q1 | 589.3 Million INR | 28.69% |
2022 Q2 | 614.02 Million INR | 4.19% |
2022 Q4 | 636.14 Million INR | 1.81% |
2022 Q3 | 624.82 Million INR | 1.76% |
2021 FY | 2.2 Billion INR | 36.53% |
2021 Q1 | 614.63 Million INR | 3.5% |
2021 Q2 | 576.45 Million INR | -6.21% |
2021 Q3 | 559.79 Million INR | -2.89% |
2021 Q4 | 457.91 Million INR | -18.2% |
2020 FY | 1.61 Billion INR | 15.86% |
2020 Q2 | 337.99 Million INR | 22.69% |
2020 Q3 | 410.5 Million INR | 21.45% |
2020 Q4 | 593.84 Million INR | 44.66% |
2020 Q1 | 275.48 Million INR | -4.58% |
2019 Q1 | 381.89 Million INR | 11.23% |
2019 Q3 | 399.35 Million INR | 22.35% |
2019 Q4 | 288.7 Million INR | -27.71% |
2019 FY | 1.39 Billion INR | 10.03% |
2019 Q2 | 326.4 Million INR | -14.53% |
2018 FY | 1.26 Billion INR | 2.46% |
2018 Q4 | 343.34 Million INR | 6.21% |
2018 Q3 | 323.28 Million INR | 13.72% |
2018 Q2 | 284.27 Million INR | -9.57% |
2018 Q1 | 314.35 Million INR | -7.88% |
2017 FY | 1.23 Billion INR | 20.68% |
2017 Q4 | 341.23 Million INR | 2.58% |
2017 Q3 | 332.64 Million INR | 12.11% |
2017 Q2 | 296.7 Million INR | 17.98% |
2017 Q1 | 251.49 Million INR | -7.58% |
2016 FY | 1.02 Billion INR | 26.39% |
2016 Q3 | 283.28 Million INR | 9.65% |
2016 Q1 | 242.3 Million INR | 29.64% |
2016 Q2 | 258.36 Million INR | 6.63% |
2016 Q4 | 272.13 Million INR | -3.94% |
2015 FY | 812.06 Million INR | 40.49% |
2015 Q4 | 186.9 Million INR | -16.13% |
2015 Q3 | 222.83 Million INR | 2.67% |
2015 Q2 | 217.04 Million INR | 17.14% |
2015 Q1 | 185.28 Million INR | 31.94% |
2014 Q4 | 140.43 Million INR | -6.73% |
2014 Q3 | 150.55 Million INR | 3.41% |
2014 FY | 578.03 Million INR | 26.09% |
2014 Q2 | 145.58 Million INR | 2.92% |
2014 Q1 | 141.46 Million INR | 20.83% |
2013 Q1 | 98.4 Million INR | 30.46% |
2013 FY | 458.41 Million INR | 18.46% |
2013 Q2 | 95.33 Million INR | -3.13% |
2013 Q4 | 117.07 Million INR | -20.68% |
2013 Q3 | 147.6 Million INR | 54.83% |
2012 Q4 | 75.43 Million INR | -22.77% |
2012 Q2 | 118.44 Million INR | 24.12% |
2012 Q3 | 97.66 Million INR | -17.54% |
2012 Q1 | 95.42 Million INR | -3.72% |
2012 FY | 386.97 Million INR | 15.96% |
2011 Q3 | 81.18 Million INR | 0.0% |
2011 Q4 | 99.11 Million INR | 22.09% |
2011 FY | 333.71 Million INR | 10.66% |
2010 FY | 301.58 Million INR | 20.98% |
2009 FY | 249.28 Million INR | 24.1% |
2008 FY | 200.87 Million INR | 16.85% |
2007 FY | 171.91 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aarti Drugs Limited | 1.16 Billion INR | -1.637% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 61.404% |
Albert David Limited | 1.02 Billion INR | -15.635% |
Alembic Limited | 872.45 Million INR | -36.005% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -17298.666% |
Hester Biosciences Limited | 908.84 Million INR | -30.561% |
Hikal Limited | 4.46 Billion INR | 73.418% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 44.139% |
Ind-Swift Limited | 946.56 Million INR | -25.357% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 46.089% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -187.709% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -10.464% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -631.433% |
Medico Remedies Limited | 59.67 Million INR | -1888.419% |
Morepen Laboratories Limited | 1.98 Billion INR | 40.296% |
Procter & Gamble Health Limited | 2.99 Billion INR | 60.386% |
RPG Life Sciences Limited | 1.63 Billion INR | 27.448% |
Sigachi Industries Limited | 579.88 Million INR | -104.624% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.23% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 15.412% |
Themis Medicare Limited | 1.12 Billion INR | -5.4% |
Unichem Laboratories Limited | 6.72 Billion INR | 82.358% |
Vaishali Pharma Limited | 84.02 Million INR | -1312.118% |
Venus Remedies Limited | 1.91 Billion INR | 38.079% |
Windlas Biotech Limited | 1 Billion INR | -17.891% |
ZIM Laboratories Limited | 1.01 Billion INR | -17.129% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 92.523% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -160.454% |
FDC Limited | 3.49 Billion INR | 66.095% |
Jubilant Pharmova Limited | 14.45 Billion INR | 91.791% |
Nectar Lifesciences Limited | 932.7 Million INR | -27.221% |
Orchid Pharma Limited | 800.77 Million INR | -48.181% |
Alkem Laboratories Limited | 32.83 Billion INR | 96.386% |
Bajaj HealthCare Limited | 985.34 Million INR | -20.424% |
Brooks Laboratories Limited | 51.18 Million INR | -2218.462% |
Eris Lifesciences Limited | 4.94 Billion INR | 75.994% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 89.807% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 53.542% |
Innova Captab Limited | 931.03 Million INR | -27.449% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -170.571% |
Wanbury Limited | 978.96 Million INR | -21.208% |
Lupin Limited | 125.09 Billion INR | 99.051% |
Sakar Healthcare Limited | 204.07 Million INR | -481.436% |
Aurobindo Pharma Limited | 55.65 Billion INR | 97.868% |
Divi's Laboratories Limited | 14.17 Billion INR | 91.626% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 52.028% |
Mankind Pharma Limited | 29.27 Billion INR | 95.946% |
Sequent Scientific Limited | 2.9 Billion INR | 59.109% |
Laurus Labs Limited | 11.9 Billion INR | 90.037% |
Neuland Laboratories Limited | 2.92 Billion INR | 59.499% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 91.978% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 97.473% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.052% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 43.335% |
Wockhardt Limited | 8.48 Billion INR | 86.007% |
Bal Pharma Limited | 555.62 Million INR | -113.559% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 98.762% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 16.392% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -1935.734% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 45.432% |
Shilpa Medicare Limited | 3.33 Billion INR | 64.411% |
Valiant Laboratories Limited | 138.02 Million INR | -759.666% |
Ajanta Pharma Limited | 30.46 Billion INR | 96.105% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -8248.617% |
Granules India Limited | 10.31 Billion INR | 88.494% |
Medicamen Biotech Limited | 335.16 Million INR | -254.029% |
Ipca Laboratories Limited | 18.98 Billion INR | 93.751% |
Syncom Formulations (India) Limited | 345.63 Million INR | -243.309% |
Piramal Enterprises Limited | 63.65 Billion INR | 98.136% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 94.461% |
NATCO Pharma Limited | 10.05 Billion INR | 88.203% |
Suven Life Sciences Limited | 109.75 Million INR | -981.174% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -2470.823% |
Strides Pharma Science Limited | 9.16 Billion INR | 87.049% |
Indoco Remedies Limited | 12.06 Billion INR | 90.162% |
Alpa Laboratories Limited | 127.38 Million INR | -831.535% |
Lasa Supergenerics Limited | 291.17 Million INR | -307.519% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 61.434% |